Unternehmen Ibere Pharmaceuticals
Aktien
A3CPP8
KYG468431013
IBER
Holdinggesellschaften
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Osagie Imasogie
CEO | Chief Executive Officer | 62 | - |
Lisa Gray
DFI | Director of Finance/CFO | 59 | - |
Zoltan Kerekes
COO | Chief Operating Officer | 58 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Louis J. Vollmer
BRD | Director/Board Member | - | - |
Osagie Imasogie
CEO | Chief Executive Officer | 62 | - |
Elaine Jones
BRD | Director/Board Member | 69 | - |
Calvin Johnson
BRD | Director/Board Member | 57 | - |
Lisa Gray
DFI | Director of Finance/CFO | 59 | - |
Zoltan Kerekes
COO | Chief Operating Officer | 58 | - |
Henrietta Ukwu
BRD | Director/Board Member | 64 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 3 450 000 | 0 | 0 | 80,00 % |
Aktie B | 1 | 13 800 000 | 13 800 000 ( 100,00 %) | 0 |
Unternehmenskontakt
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+178,17 % | 6,65 Mrd. | |
-6,60 % | 928 Mio. | |
+2,00 % | 981 Mio. | |
+41,91 % | 872 Mio. | |
+22,85 % | 804 Mio. | |
+1,82 % | 664 Mio. | |
+21,31 % | 552 Mio. | |
-.--% | 600 Mio. | |
-90,22 % | 593 Mio. |